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Advances in noninvasive imaging permit the
preoperative evaluation of many vascular patients
without conventional contrast arteriography (CA).
Magnetic resonance angiography (MRA) has been
used as a means of effectively evaluating the aortoil-
iac system1,2 and the infrainguinal vessels,3 and it
can be used effectively as the sole preoperative
imaging modality before peripheral arterial recon-
struction.4,5 Arterial duplex scanning has been used
as a means of effectively screening for bypass graft
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Purpose: Conventional pre-endovascular procedural evaluation uses both noninvasive
testing and diagnostic arteriography. Diagnostic and therapeutic procedures often must
be performed separately because of concerns about excessive contrast administration or
inappropriate location of vascular access for the interventional procedure. We wanted to
determine if patients could successfully undergo endovascular procedures based on non-
invasive modalities alone.
Methods: One hundred nineteen consecutive patients requiring intervention for lower-
extremity ischemia were evaluated by means of physical examinations and segmental pres-
sure measurements. Patients then underwent magnetic resonance angiography (MRA) to
image native vessels or duplex scanning for failing bypass grafts. Suitable patients under-
went endovascular procedures with “road map” arteriography, which was compared with
preoperative duplex scanning or MRA findings. Costs of the conventional and noninvasive
approaches were compared, on the basis of estimated hospital cost schedule.
Results: Sixty consecutive endovascular procedures were performed in 56 patients (105
lesions angioplastied), either alone (30, 50%) or in combination (30, 50%) with another
vascular reconstruction. Completely noninvasive evaluation was accomplished in 43 pro-
cedures (72%), either by means of duplex scanning (11, 18%) or MRA (32, 53%).
Conventional arteriography (CA) was required in 2 patients (3%) because of MRA con-
traindications and in 1 patient because of complex previous arterial reconstruction.
Fourteen patients had earlier CAs. The findings of the noninvasive modalities were con-
firmed in every case by means of intraoperative arteriography, and no additional lesions
were revealed (no false positive or negative studies). After endovascular interventions, the
mean patient ankle-brachial index (ABI) improved from 0.64 ± 0.03 to 0.81 ± 0.03 (P <
.001) and the mean limb-status category improved from 3.4 ± 0.2 to 0.8 ± 0.2 (P < .001).
There were 4 initial technical failures (7%), 1 morbidity (1%), and no mortalities. The
noninvasive approach was less costly than if preprocedural diagnostic CA had been used,
allowing $551 saved for each duplex scanning case and $235 saved for each MRA case. If
the cost of a short-stay unit after a diagnostic arteriogram was included, the savings were
greater: $695 saved for each duplex scanning case and $379 saved for each MRA case.
Conclusion: Endovascular procedures can be performed based on preprocedural nonin-
vasive modalities alone. For patients requiring endovascular procedures, knowledge of
the arterial anatomy before obtaining arterial access avoids the need for additional punc-
tures or sessions (eg, antegrade puncture for femoral angioplasty after retrograde punc-
ture for the diagnostic arteriogram). This approach is less costly than performing pre-
procedural diagnostic arteriography and avoids the hazards of arterial puncture and
nephrotoxic contrast agents.  (J Vasc Surg 1998;28:995-1005.)
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included solely MRA (n = 32), arterial duplex
sonography (n = 11), and CA (n = 17).
Procedures. After diagnostic imaging, patients
were counseled about their surgical options. Fifty-
nine patients underwent open arterial reconstruc-
tions, whereas 56 patients subsequently underwent
endovascular procedures, with or without simultane-
ous open arterial reconstruction. All patients who
had failing bypass grafts detected during duplex 
graft surveillance underwent graft revision, either
with balloon angioplasty or open surgical revision.
Fifty-six patients underwent a total of 60 endovas-
cular procedures (2 patients underwent 2 endovas-
cular procedures, and 1 patient underwent 3
endovascular procedures). Multiple lesions were
addressed synchronously when possible.
All procedures were performed in the operating
room by a vascular surgeon (J.P.C.). Nearly all
patients undergoing angioplasty alone were given a
local anesthetic with intravenous sedation. Patients
undergoing angioplasty and simultaneous “open”
arterial reconstruction were given a regional or gen-
eral anesthetic. In the latter patient cohort, arterial
access was routinely obtained via direct arterial cut-
down on the femoral artery and the introduction of
an arterial sheath over a 0.035-in guidewire. Among
patients without requisite open arterial exposure,
arterial access was always attempted by means of
either retrograde or anterograde percutaneous arte-
rial puncture, followed by the introduction of arter-
ial sheaths with a modified Seldinger technique.
Among the 60 endovascular procedures, 40 were
performed with entirely percutaneous vascular
access, whereas 20 procedures involved arterial
access via the cutdown approach. All patients were
systemically heparinized after the introduction of
arterial sheaths and then studied angiographically in
a limited manner, by means of a portable C-arm and
fluoroscopic monitoring (OEC 9600). Focused
arteriograms were obtained by means of digital sub-
traction (DSA) and “road mapping” technique.
Hemodynamically significant lesions were defined as
lesions that reduced luminal diameter by 50% or
more, as assessed on a single arteriographic view.
More marginal lesions (50% to 60% diameter reduc-
tion) were evaluated further to confirm their hemo-
dynamic significance. This was performed by obtain-
ing additional oblique angiographic views and by
passing a 5-F straight angiographic catheter across
the lesion and measuring pullback pressure gradi-
ents. Vasodilator agents were not used to enhance
pressure gradients. An unenhanced pressure gradi-
ent of more than 20 mm Hg across a lesion was
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abnormalities.6,7,8 Lower extremity arterial bypass
graft lesions detected by means of surveillance
duplex scanning are commonly verified with CA
before formal graft revision.9 Recently, the feasibil-
ity of using duplex ultrasonography as the sole
method of bypass graft evaluation before revision
has been documented, associated with marked cost
savings.10 The feasibility and cost-effectiveness of
an entirely noninvasive preoperative vascular patient
evaluation before endovascular procedures was
studied.
METHODS
Patient selection and initial evaluation.
From June 1997 through January 1998, 119 con-
secutive patients with peripheral vascular occlusive
disease who had been referred to a single university
hospital vascular surgeon (J.P.C.) underwent either
endovascular or open surgery. Included in this
group were both symptomatic patients with native
arterial disease and asymptomatic patients with fail-
ing bypass grafts detected by means of duplex ultra-
sonography.11 All failing bypass grafts were reversed
saphenous vein grafts in the infrainguinal position.
All patients underwent comprehensive history and
physical examinations, and a clinical category for
chronic limb ischemia was assigned to each patient
according to the reporting standards of the Society
for Vascular Surgery/International Society for
Cardiovascular Surgery (SVS/ISCVS).12,13 Each
patient’s lower-extremity arterial status was assessed
physiologically with segmental pressure measure-
ments, and ankle-brachial indices (ABIs) were cal-
culated.
Patient imaging. Aortoiliac and infrainguinal
lower-extremity arterial anatomy was defined by
means of MRA with techniques previously
described.3,14 Fourteen patients, having previously
undergone CA at referring hospitals, did not under-
go a second angiography (MRA or CA). Two
patients with contraindications to MRA (1 patient
with a pacemaker, another who was claustrophobic)
and 1 patient with previous complex lower-extremi-
ty arterial reconstructions were referred for diagnos-
tic CA. All patients with failing bypass grafts detect-
ed by means of duplex ultrasonography were treated
with their preprocedural duplex scanning study
alone, with no additional invasive evaluation of their
grafts. These patients (n = 11) were referred for
either endovascular or open graft revision, as indi-
cated by the graft’s appearance on duplex ultra-
sonography. The preoperative assessment among all
patients treated with an endovascular procedure
required for it to be considered “hemodynamically
significant.” Lesions that reduced diameter by less
than 50% were not considered to be hemodynami-
cally significant.
Significant lesions were treated with convention-
al balloon angioplasty. Technical success was defined
as anatomic resolution of the lesion waist at the time
of angioplasty, with less than a 30% residual stenosis.
Physiologic success was defined as improved lower-
extremity arterial perfusion, documented by means
of an improvement in the ABI of at least 0.10.
Clinical success was defined as symptomatic
improvement of at least 1 clinical category. 
Eleven patients underwent road mapping arteri-
ography to evaluate arterial duplex ultrasonographic
abnormalities. Abnormalities included those consis-
tent with graft stenosis (graft peak systolic velocity
less than 300 cm/s or less than 3:1 peak systolic
velocity ratios in adjacent graft segments), and
inflow or outflow arterial disease resulting in graft
peak systolic velocities of less than 40 cm/s. All
lesions detected by means of duplex ultrasonography
were verified at the time of angioplasty with a limit-
ed focused arteriogram. The bypass graft, its anasto-
motic ends, and runoff were visualized by means of
this arteriogram, but the entire arterial inflow to the
graft was not routinely visualized. Grafts were
accessed either percutaneously (n = 6; direct graft
puncture, ipsilateral, or contralateral femoral artery)
or via limited cutdown over the vein graft (in anti-
coagulated patients). Arterial sheaths were intro-
duced over guidewires advanced fluoroscopically,
and balloon catheters were subsequently advanced
through these sheaths. Arterial sheaths placed via
direct arterial cutdown were removed before wound
closure. After the completion of all endovascular
procedures, patients recovered in a postoperative
recovery room. Activated clotting times (ACT) were
monitored in the recovery room, and percutaneous-
ly inserted arterial sheaths were removed when
ACTs returned to less than 150 seconds.
Comparison of noninvasive imaging with
conventional arteriograms. Preoperative noninva-
sive imaging was compared with intraoperative lim-
ited CAs in all patients that underwent endovascular
procedures. The results of noninvasive imaging were
compared with CA for the number and location of
hemodynamically significant lesions (50% or more
diameter reduction).
Postprocedural patient evaluation. All patients
undergoing either balloon angioplasty or balloon
angioplasty with arterial bypass surgery were evalu-
ated 1 to 4 weeks postoperatively by means of seg-
mental pressure measurements. Patients undergoing
treatment of graft stenosis underwent a second arte-
rial duplex scanning of their grafts 2 to 3 weeks after
angioplasty. All patients were interviewed and exam-
ined by the same surgeon during their follow-up
noninvasive examinations, and their clinical vascular
status was reassessed.
Analysis of cost. Cost analysis was performed
by analyzing the total hospital cost estimates for the
different diagnostic modalities at the University of
Pennsylvania Medical Center (Table I). Hospital
costs (both direct and indirect costs) were calculated
by the corporate finance department of the medical
center and were routinely used in formulas with pre-
vailing Medicare fees to calculate hospital reim-
bursements. The total cost of a given diagnostic pro-
cedure was the sum of the hospital’s direct cost of
performing the procedure combined with the hospi-
tal’s indirect (overhead) costs. Sum costs for diag-
nostic arteriography included the total cost of the
radiologic procedure itself and the total cost of a 6-
hour stay in the ambulatory recovery room (no
overnight recovery). The sum cost of an MRA
included the total cost of studying the aortoiliac sys-
tem (“pelvis”) and a single extremity runoff. Sum
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Table I. Cost analysis of performing solely noninvasive vs conventional preprocedural contrast arteriogra-
phy evaluation of patients before endovascular procedures
Ambulatory Cost saving 
Pre-endovascular Total cost recovery compared with
procedure modality of modality* room: Total cost Sum cost contrast arteriography
Aortagram with runoff $1208 $144 $1352 N/A
Magnetic resonance angiography of $973 N/A $973 $379
pelvis and lower extremity
Unilateral lower-extremity arteriogram $705 $144 $849 N/A
Duplex ultrasonography $154 N/A $154 $695
*Based on 1998 cost schedule at the Hospital of the University of Pennsylvania. Total costs include both the direct cost of study admin-
istration and the best estimates of overhead indirect costs.
costs for duplex scanning and MRA were then com-
pared with the sum costs associated with CA.
Differences were expressed as cost savings.
Statistical analysis. Clinical status categories
and ABIs were compared in all patients before and
after endovascular procedures. Quantitative data
were expressed as means and standard errors (mean
± SE). Mean clinical categories were compared with
the Wilcoxon signed rank test, whereas mean ABIs
were compared with the Student t test for paired
data. Differences in clinical or physiologic status
were considered significant if P < .05.
RESULTS
Patients and demographics. Fifty-six consecu-
tive patients underwent 60 consecutive endovascular
procedures during the study period (Table II). Most
of these patients were men (57%), had hypertension
(71%), and smoked (55%). In addition, 14% of
patients had significant renal insufficiency (serum
creatinine levels greater than 1.5 mg/dL), and 4
patients (7%) were dialysis-dependent before their
endovascular procedures. Notably, no patients had
significant rises in their serum creatinine levels
(more than 0.5 mg/dL) after the endovascular pro-
cedures. The indications for intervention are shown
in Table II and include claudication (50%), rest pain
(17%), gangrene (27%), and failing bypass grafts
(7%).
Patient imaging. The presence of 44 aortoiliac
lesions, 45 native infrainguinal lesions, and 16
bypass graft lesions was suggested by means of pre-
operative imaging (Table III). Every lesion predict-
ed by means of preoperative imaging was confirmed
at the time of intervention with initial digital sub-
traction arteriography (Figs 1 and 2). Noninvasive
modality findings were confirmed by means of intra-
operative arteriography in every case, and no addi-
tional lesions were revealed (no false positive or neg-
ative studies). Five marginal lesions (50% to 60%
reduction in diameter) were evaluated with oblique
arteriographic views and pullback pressures, and all
5 were found to be hemodynamically significant (see
aforementioned criteria), with pressure gradients
consistently between 20 and 30 mm Hg.
Procedures. Percutaneous arterial access was
successfully achieved to treat 68 of 74 (92%) lesions
that otherwise required no arterial exposure. An
additional 31 lesions were treated with angioplasty
via an open arterial cutdown that was requisite
because of either concomitant arterial bypass or anti-
coagulation requirements. Forty-four balloon angio-
plasties were performed for aortoiliac lesions (Table
IV), with an immediate technical success rate of 93%
(41 of 44). The procedural failures occurred in 2
patients, 1 patient with a wire perforation of an
external iliac artery requiring open arterial repair and
another with severe bilateral aortoiliac occlusive dis-
ease that required subsequent elective aorto-
bifemoral reconstruction. Forty-five balloon angio-
plasties were performed for native lesions of the
infrainguinal vessels (Table IV), with an initial tech-
nical success rate of 98% (44 of 45). The single pro-
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Table II. Demographics and clinical characteristics
among patients undergoing 60 consecutive
endovascular procedures
Number of Patients 56
Mean age 69 (range, 50 to 87)
Men 32 (57%)
Women 24 (43%)
Diabetes 18 (30%)
Hypertension 40 (71%)
Smokers 31 (55%)
Chronic renal insufficiency (serum 8 (14%)
creatinine levels >1.5 mg/dL)
Dialysis dependent 4 (7%)
Clinical status before endovascular 
procedure
Claudication (Clinical 30 (50%)
categories 1 to 3*)
Rest pain (Clinical categories 10 (17%)
4 and 5)
Gangrene (Clinical category 6) 16 (27%)
Asymptomatic (Graft scan  4 (7%)
abnormality, clinical category 0)
*Based on recommended recording standards of the Society for
Vascular Surgery/International Society for Cardiovascular
Surgery.
Table III. Anatomic and procedural characteristics
of 105 consecutive lesions angioplastied among 56
patients undergoing 60 endovascular procedures
Lesions treated
with endovascular
procedures (%)
Lesion location
Aortoiliac vessels 44 (42%)
Infrainguinal vessels 45 (43%)
Bypass grafts 16 (15%)
Angioplasty of native vessels
Isolated angioplasty 53 (60%)
With concomitant arterial bypass 36 (40%)
Technique
Percutaneous balloon angioplasty 68 (65%)
Angioplasty via arterial cutdown 37 (35%)
Number of lesions angioplastied/procedure
Single lesion 32 (53%)
2 lesions 17 (28%)
3 lesions 7 (12%)
4 or more lesions 4 (7%)
cedural failure resulted from the inability to ade-
quately dilate a heavily calcified superficial femoral
artery in a patient undergoing dialysis. Because of
preoperative discussions of this eventuality, the pro-
cedure was converted to a conventional femoral
artery to popliteal artery bypass, performed at the
same session. Sixteen balloon angioplasties were per-
formed on arterial bypass graft stenoses (Table IV),
with a technical success rate of 94% (15 of 16). 
Clinical and physiological assessment. The
clinical success rate among aortoiliac lesion angio-
plasty was 91% (40 of 44), and the physiologic suc-
cess rate among aortoiliac lesion angioplasty was
73% (32 of 44). The clinical success rate among all
infrainguinal lesion angioplasties performed was 73%
(33 of 45), and the physiologic success rate among
all infrainguinal lesion angioplasties performed was
87% (39 of 45). Among procedures performed on
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Fig 1. Noninvasive arterial evaluation and endovascular treatment of a 70-year-old man with diabetes and
severe right lower-extremity claudication. A, High-grade lesion of the right common iliac artery was
demonstrated by means of a preoperative evaluation with magnetic resonance angiography. B, The pres-
ence of this lesion was confirmed by means of intraoperative digital subtraction arteriography. C, The lesion
was subsequently treated with balloon angioplasty, with complete resolution of claudication symptoms.
A
CB
bypass grafts, clinical success was documented in
69% (11 of 16) of lesions treated.
Evaluation of physiologic changes in limb perfu-
sion revealed significant preprocedural to postproce-
dural improvements in mean ABIs among patients
undergoing aortoiliac (0.57 ± 0.05 vs 0.79 ± 0.05),
and infrainguinal (0.61 ± 0.04 vs 0.83 ± 0.04) revas-
cularizations (Table IV). The SVS/ISCVS clinical
assessment scores among these cohorts were likewise
significantly improved (3.7 ± 0.2 vs 0.5 ± 0.3 and
3.6 ± 0.2 vs 1.1 ± 0.4, respectively).
Failing bypass grafts. Eleven patients under-
went endovascular treatment of 16 bypass graft
lesions diagnosed by means of duplex arterial graft
scanning. Six grafts were accessed percutaneously,
whereas 5 were accessed via small incisions to avoid
interrupting anticoagulation for percutaneous punc-
ture or sheath removal. Eighty-one percent (13 of
16) of lesions treated were midgraft lesions, and 2
balloon angioplasties were combined with limited
surgical procedures (Table V). Ten of 11 (91%) fail-
ing bypass grafts were treated successfully with
endovascular therapy. Technical success documented
by means of angiography was always supplemented
with a second duplex scan evaluation. After endovas-
cular therapy, 10 of the 11 failing grafts (15 of 16
lesions) demonstrated resolution of graft scan
abnormalities as previously defined. Among stenotic
graft segments, mean segmental velocities dropped
from 353 ± 51 cm/s to 48 ± 16 cm/s (P < .01) by
means of duplex scan examination.
Cost analysis. Notable cost-reduction was doc-
umented with the use of noninvasive screening
modalities alone before endovascular procedures
(Table I). The cost of a CA with lower extremity
runoff exceeds the cost of an MRA of the pelvis and
lower extremity, and the cost differential is larger
when the cost of the short-procedure recovery room
is included. Likewise, the cost-savings associated
with the use of only duplex scanning before
endovascular intervention, rather than CA, is even
greater. The noninvasive evaluation saved $551 per
duplex scanning case and $235 per MRA case. If the
cost of a 6-hour stay in the short-stay unit recovery
room after CA was included, the net savings per
duplex scanning case increased to $695, and the net
savings per MRA case increased to $379.
DISCUSSION
We found that endovascular procedures can be
effectively performed based entirely on noninvasive
preprocedural evaluation. We found no false positive
or negative MRA studies when compared with intra-
operative preprocedural contrast “road map” arteri-
ography. The use of MRA to evaluate patients with
primary lower-extremity occlusive disease proved to
be more cost-effective than CA. Other authors have
also found that duplex imaging of failing lower-
extremity arterial bypass grafts is sufficient to pro-
ceed with open surgical repair.15 The use of duplex
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Table IV. Clinical and physiological assessment of patients before and after endovascular procedures per-
formed on native vessels and bypass grafts
Number with
Balloon simultaneous Preprocedural Postprocedural Preprocedural Postprocedural
angioplasty “open surgery”* Technical clinical clinical ankle ankle
location Number (% of total) success rate† status score status score brachial index brachial index
Aortoiliac 44 25 (57%) 41/44 (93%) 3.7 ± 0.2 0.5 ± 0.3‡ 0.57 ± 0.05 0.79 ± 0.05‡
Infrainguinal 45 11 (24%) 44/45 (98%) 3.6 ± 0.2 1.1 ± 0.4‡ 0.61 ± 0.04 0.83 ± 0.04‡
Bypass grafts 16 2 (13%) 15/16 (94%) 2.3 ± 0.6 0.5 ± 0.5‡ 0.80 ± 0.10 0.89 ± 0.09§
Values are mean ± SE.
*Arterial bypass or endarterectomy. 
†Technical success defined as successful lesion effacement with less than 30% residual stenosis.
‡P <.01 compared with status before endovascular treatment.
§No significant difference compared with status before endovascular treatment.
Table V. Graft characteristics of 11 patients with
failing bypass grafts treated with balloon angioplas-
ty after noninvasive evaluation
Total lesions treated 16
Bypass type
Femoral-popliteal artery bypass graft 5
Femoral-tibial artery bypass graft 6
Lesion location
Midgraft lesion 13
Anastomotic lesion 1
Inflow/outflow lesion 2
Concomitant open surgical procedure 2
(outflow thrombectomy
and patch angioplasty of 
second graft lesion)
ultrasonography for patients with failing bypass
grafts was likewise safe and cost-effective when com-
pared with CA in making clinical decisions before
bypass graft revision. Repair of lesions detected by
means of the noninvasive modalities led to signifi-
cant improvement in patients’ clinical and objective
measures of ischemia.
The ability to accurately image the vascular sys-
tem of patients noninvasively offers multiple
potential advantages. Other authors have demon-
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Fig 2. Noninvasive arterial evaluation and endovascular treatment of a 52-year-old woman with right
lower-extremity gangrene. A, A patent end-to-side aortoiliac bypass and B, the presence of a short occlu-
sion of the right superficial femoral artery were shown by means of a preoperative evaluation with mag-
netic resonance angiography. C, The presence of the high-grade lesion, shown here traversed by a recanal-
ization wire was confirmed by means of intraoperative digital subtraction arteriography. D, The lesion was
subsequently treated with balloon angioplasty. The patient underwent simultaneous amputation of a sin-
gle toe. Preprocedural magnetic resonance angiography allowed for the appropriate selection of antegrade
right femoral artery puncture. If preprocedural CA had been used by retrograde femoral artery catheteri-
zation, a second puncture or session would have been required to perform the intervention.
A
C D
B
strated that noninvasive techniques that obviate
the need for arterial puncture or contrast agent
administration are potentially safer and less mor-
bid than CA.16-19 Although patients with mild
renal insufficiency can often undergo CA without
significant morbidity, this is most often achieved
by limiting contrast agent administration and fre-
quently limiting the comprehensiveness of the
resultant study. Likewise, although patients with
more marked renal insufficiency can undergo CO2
angiography, this technique is not practically
applicable to the evaluation of the entire aortoiliac
and infrainguinal vascular anatomy. Because 14%
of patients in this study had chronic renal insuffi-
ciency, the advantage of providing a comprehen-
sive anatomic evaluation while minimizing con-
trast agent exposure is apparent. 
An additional advantage of preprocedural nonin-
vasive evaluation is the ability to choose an appro-
priate location and orientation for arterial access to
perform the intervention. For example, knowledge
of isolated infrainguinal short-segment arterial
occlusive disease permits the appropriate single
placement of anterograde arterial access for subse-
quent angioplasty (Fig 2). The need for the addi-
tional retrograde arterial access usually obtained
during the diagnostic angiogram can be eliminated.
This obviates the need for a “second trip” to the
interventional unit when access inappropriate for
intervention has been chosen because of the need
for preprocedural diagnostic arteriography.
The noninvasive evaluation of vascular disease is
cost-effective, as demonstrated in the evaluation of
both carotid and peripheral vascular disease.20,21
Using a current cost schedule (rather than charge or
reimbursement schedule), we found the noninva-
sive approach to imaging before endovascular pro-
cedures to be cost-effective. The cost of MRA is less
than the cost of routine CA, and the addition of the
necessary short-stay unit cost increases the cost
associated with the CA. The cost-savings attributed
to the sole use of bypass graft duplex ultrasonogra-
phy before endovascular procedures proved to be
even more substantial. Minimally invasive proce-
dures may prove to be less cost-effective overall
than the more durable conventional operative pro-
cedures. This will only become clear when the long-
term results of such procedures are compared in a
prospective fashion.
Although the sole use of duplex scanning to
identify lower-extremity native arterial lesions suit-
able for percutaneous transluminal angioplasty has
been described,22 we prefer to obtain a more
anatomically complete image before an invasive pro-
cedure. Lower-extremity arterial duplex mapping is
not as accurate as MRA, and the technique is very
operator dependent and time-consuming. We have
found greater concordance between operative plans
formulated based on MRA and those based on CA
in patients having both studies available and
reviewed by surgeons and radiologists in blinded
fashion.1,3,23
The noninvasive evaluation of patients before
endovascular procedures is increasingly important
given the patient population undergoing these pro-
cedures. Candidates for endovascular therapy, often
patients with lower-extremity claudication, are at
lesser risk of limb-loss than patients with rest pain or
gangrene. These patients should be exposed to the
least possible risk during both diagnosis and inter-
vention. Other candidates for endovascular therapy
are assessed to be prohibitively high-risk for “open”
operative surgery. These “high-risk” patients are
likewise logical candidates for the least invasive pre-
operative evaluation possible in performing the
required intervention. Both patient subsets demand
the least invasive approach possible that allows accu-
rate imaging and expedient intervention. 
The ability to successfully apply such noninvasive
evaluation of vascular patients requires an individual
institution’s validation of its MRA and duplex ultra-
sonography compared with the reference standard of
CA. At present, the results of MRA vary among
institutions, based on differences in the software and
techniques used (eg, 2-dimensional time-of-flight
imaging vs 3-dimensional imaging with gadolinium
enhancement).4,5 Likewise, results of duplex graft
scanning continue to be significantly operator-
dependent.24 The reliable application of these non-
invasive evaluations before intervention should be
assessed by each institution by means of rigorous
comparison with CA. Previously, we and other
authors have found MRA to be highly accurate as a
means of detecting significant lesions of the aorta
through pedal vessels when compared with
CA.1-5,14,19 In these studies, low false-positive and
false-negative rates were produced with MRA. In the
present study, as only limited CA was used, false-
negative MRA or duplex scanning studies may have
gone undetected. However, the rate of false-nega-
tive MRA studies in our earlier validation protocols
has been 0 to 1.4%.1,3
The application of noninvasive preprocedural
evaluation is not always feasible. Among referred
patients who did not undergo previous diagnostic
imaging, 3% in this study were not candidates for
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MRA, either because of contraindications (claustro-
phobia or a pacemaker) or unusually complex recon-
structed arterial anatomy. This is consistent with
previously reported rates for MRA contraindica-
tions4 in patients with infrainguinal arterial occlusive
disease. 
Endovascular procedures can be accurately and
effectively performed based on preprocedural nonin-
vasive techniques alone, by means of directed arteri-
ography at the time of intervention. Noninvasive
evaluation by means of duplex scanning or MRA is
substantially safer and cost-effective when compared
with routine diagnostic CA before endovascular pro-
cedures. Noninvasive imaging can obviate the need
for invasive preprocedural CA in many patients. 
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Dr Luis A. Queral (Baltimore, Md). I congratulate
the authors for sharing this timely work with the members
of the Eastern Vascular Society.
This paper highlights the suitability of the noninvasive
laboratory and magnetic resonance imaging as adequate
preoperative testing methods in selecting patients for
endovascular procedures. The results presented under-
score the lessening need for conventional arteriography in
vascular surgery. This is not at all surprising.
We have seen the near elimination of arteriography in
patients with carotid disease and in those with abdominal
aortic aneurysmal disease during the past 15 years. It is
now increasingly clear that diagnostic conventional arteri-
ography should be used selectively rather than routinely.
DISCUSSION
It has become a very tarnished gold standard. It is also rel-
evant to note that today cost analysis is an important con-
sideration in selecting which procedures should be per-
formed. Good patient care can be cost-effective; it is our
responsibility to make it so, and the results presented by
Dr Levy clearly show this.
I do have a number of questions relevant to this pre-
sentation.
The first one relates to magnetic resonance imaging.
Do you really think it’s necessary? I note that in patients
with failing bypasses only duplex scanning was performed
as an image modality in your vascular laboratory. Why
can’t all patients with lower-extremity ischemia be evalu-
ated only by means of those modalities available to you in
the standard noninvasive vascular laboratory? What would
be the cost savings if such an approach was used and reso-
nance imaging was totally omitted?
Second, you report the cost of $1352 for convention-
al arteriography, including recovery room costs, at the
University of Pennsylvania. I have a hard time differentiat-
ing hospital costs from real costs, that is, what the patient
and the insurance company are charged. I do believe that
your data would be more relevant if you picked patient
charges rather than hospital costs. Can you comment on
this? In fact, in most hospitals, we consider the actual cost
of conventional arteriography to be in the $4000 range.
Finally, do you apply noninvasive testing, as described
in this report, only to patients who are candidates for
endovascular surgery? How do you evaluate patients
requiring a distal bypass for limb salvage? Can the same
criteria be applied? And, again, can you obviate the need
for preoperative conventional arteriography when you
have the capability in the operating room for performing
so-called diagnostic or delineating arteriography?
Again, I congratulate Dr Levy and his colleagues for
their work and look forward to their future contributions
on this topic to our Society.
Thank you.
Dr Mark M. Levy. I would like to thank Dr Queral for
his insightful comments and questions.
Regarding the application of duplex scanning rather
than magnetic resonance angiography, other groups have
reported the successful use of duplex scanning for patient
assessment before both conventional bypass grafting
surgery and endovascular procedures. Although this has
not been the practice at our institution, our impression is
that it would be difficult to consistently acquire as much
anatomic information from duplex ultrasound as from
magnetic resonance angiography. This is particularly true
if one desires to image the iliac vessels, which can be diffi-
cult to image reliably in some patients. We believe that the
ease with which magnetic resonance angiography can
simultaneously image bilateral inflow and outflow vessels
make it a preferable method at the present time.
Regarding the issue of comparing the expense of dif-
ferent imaging methods, we have examined differences in
hospital cost, in patients charges, and in hospital reim-
bursement. We would argue that the hospital cost is the
most relevant entity to evaluate, especially on a societal
level. Cost is what we are trying to save the medical insti-
tution, not charges. Hospital charges can vary significant-
ly from region to region and from hospital to hospital,
without clear evidence that they reflect regional cost dif-
ferences. In addition, Medicare reimbursement schedules
are on the basis of blends of estimated costs and regional-
ly adjusted charges. As both charge and reimbursement
may vary substantially depending on the scenario, I would
argue that cost is the most relevant variable to use in com-
parisons of expense.
Regarding the potential application of noninvasive
evaluation before formal arterial bypass grafting proce-
dures, this is indeed our practice. As has been previously
described by our group, candidates for more convention-
al aortoiliac and infrainguinal reconstructions can be eval-
uated with only noninvasive studies.
Dr Keith D. Calligaro (Philadelphia, Pa). I have two
questions; maybe you can answer them one at a time.
The first one has to do with your cost analysis. When
you were comparing the cost of arteriography with the cost
of magnetic resonance angiography, and later bringing
patients to the operating room for a balloon angioplasty,
did you look at the cost savings of doing the balloon angio-
plasty at the same time as the arteriogram? Did you add the
cost of doing them together or separate them out?
Dr Levy. The data that we presented represent the
costs of purely diagnostic procedures. If one were to per-
form a cost analysis of the actual endovascular procedure
as well, that would inevitably be influenced by where the
procedure was done, what percentage of patients could
have an angioplasty performed simultaneously with the
diagnostic arteriogram, and what percentage of patients
would have an angioplasty performed on a different day,
as a result of inappropriate arterial access, too much con-
trast being administered during the diagnostic procedure,
etc. This could be done. However, the cost analysis per-
formed by our group was purely for the diagnostic evalu-
ation, not for the therapy.
Dr Calligaro. But again, going a little bit further with
this, 95% of patients probably can undergo an arteri-
ogram, because their kidneys are healthy. If you consider
those patients who can simply be treated with a balloon
angioplasty because they have an isolated lesion, did you
look at the cost of whether doing an arteriogram and a
balloon at the same time is cheaper than the cost of per-
forming magnetic resonance angiography and then bring-
ing them to the operating room and doing a balloon
angioplasty there? Did you look at that specifically?
Dr Levy. We did not do that cost analysis, and certain-
ly it would be interesting to evaluate. Again, one would
need to ascertain the percentage of patients who can
undergo simultaneous diagnostic arteriography and bal-
loon angioplasty. This might vary among institutions.
Dr Calligaro. My second question has to do with
duplex scanning as a means of intervening for a failing
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graft. Last year at The Society for Vascular Surgery meet-
ing, we presented our results with more than 100 failing
grafts, intervening solely with the duplex scan. And in our
results, approximately two thirds of the time we found
that this was possible; the other third of the time we felt
that a full arteriogram was necessary, because of the sug-
gested presence of more than 1 lesion or because we
weren’t quite sure where the stenosis was. What specifical-
ly are your duplex criteria when you’re willing to intervene
based solely on a duplex scan?
Dr Levy. The duplex criteria are consistent with a graft
stenosis or an inflow or outflow lesion. The criteria that we
used for a graft stenosis included a focal graft velocity that
exceeded 300 cm/sec or a relative ratio of graft velocities
in contiguous graft segments of greater than 3:1. The cri-
teria that we used for dignosing an inflow or outflow
lesion was graft flow less than 30 to 40 cm/sec.
Dr Michael B. Silva Jr. (Newark, NJ). I enjoyed your
presentation. I have a question about your selection of
patients for endovascular procedures. I noted that in your
treatment slide you indicated that roughly 20% of your
patients had either 3, 4, or more lesions treated at the time
of the procedure. What were the results within this group
of patients? And what are your criteria for abandoning
your enthusiasm for endovascular procedures and opting
for more traditional vascular reconstructions?
Dr Levy. Immediate technical results for those cases
where multiple lesions were treated were equally good. We
had few immediate technical failures.
Dr Silva. Did you look at long-term results, that is, 3,
4, and 5 lesions treated in addition to surgical bypasses?
Dr Levy. No, we have not, because the length of follow-
up time is not adequate. The data that we presented reflect
procedures that were performed within the past year.
Dr Silva. Well, then, what’s the number of lesions that
you would need to see before you would decide not to
proceed with endovascular therapeutic intervention?
Dr Levy. We have not defined a maximum number of
lesions that would preclude considering the endovascular
approach. Certainly, as the literature bears out, a diffusely
diseased vessel is probably best served with a convention-
al bypass grafting procedure. In contrast to this, short seg-
ment discrete lesions have reasonable short-term out-
comes with endovascular procedures.
Dr Peter J. Pappas (Newark, NJ). I am impressed with
the ability of physicians at the University of Pennsylvania to
perform this magnetic resonance angiography.
Dr Levy. The amount of time spent processing images
after a magnetic resonance angiography can vary, and I am
not sure that the average amount of time has been calcu-
lated. We work closely with our radiologists and routinely
review magnetic resonance angiography studies with them
at “work-stations” where the images can be actively
reviewed. Just as with conventional arteriography, routine
review of the recently performed magnetic resonance
angiography with our radiologists has proven to be equal-
ly vital in forming the best operative plan.
Dr Pappas. One last question. When you have a high-
grade stenosis on your magnetic resonance angiograph, how
do you know when you have a signal void that it’s not caused
by dropout, or whether there really is a stenosis? In the pic-
ture that you showed of a superficial femoral artery lesion,
there was a complete dropout, suggesting an obstruction,
but on the angiogram there was a high-grade stenosis that
you could pass a wire across. That’s always been my concern
with magnetic resonance angiography. How do you know
during your diagnostic evaluation whether this is a real
obstruction for which you may need an angiogram or
whether this is a high-grade stenosis for which you don’t
need the angiogram? Do you confirm your magnetic reso-
nance angiographs with a duplex, or do you proceed clini-
cally based on the magnetic resonance angiograph alone?
Dr Levy. We proceed on the basis of the information
provided with magnetic resonance angiography. It is at
times difficult to distinguish a complete occlusion from a
high-grade lesion. We will consider both the short segment
occlusions and the short segment high-grade stenoses as
reasonable candidates for an endovascular approach.
Dr Pappas. But what I’m interested in is the algorithm.
If you see a signal dropout in an magnetic resonance angio-
graph, how do you know whether it’s an occlusion or a
stenosis? What prompts you to go for the angiogram vs the
duplex scan vs straight to the operating room?
Dr Levy. With evidence by means of magnetic reso-
nance angiography of an appropriately focal lesion for
angioplasty, we will take our patients who are symptomatic
to the operating room to attempt to pass a wire across that
lesion. We do not perform any additional preprocedural
studies to differentiate the short preocclusive lesion from
the short occlusion.
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